Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07118683 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BRAZILIAN REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN PEOPLE LIVING WITH HIV/AIDS

Study acronym: BRAVO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Enrollment target: 2100 to 743
    • Primary endpoints: 2 to 1
    • Study sites: 0 to 9
    • Study description shortened, about 36 words
    • Eligibility criteria shortened, about 3 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
BRAVO proposes the establishment of a comprehensive registry of chronic noncommunicable diseases (NCDs), providing crucial data for the formulation of effective health policies for people living with HIV/AIDS (PLWHA). BRAVO is a cross-sectional study, that will collect on the study allocation sociodemographic data, risk factors related to the main NCDs, physical examination data and samples for determination of biochemical and metabolic parameters. To this end, the study will include co-participating research centers from the 5 Brazilian geographic macro-regions.
Trial Details
NCT Number NCT07118683
Lead Sponsor Hospital Alemão Oswaldo Cruz
Collaborators: Ministry of Health, Brazil
Conditions
(from sponsor)		 AIDS (Acquired Immunodeficiency Syndrome), Cardiovascular and Cerebrovascular Diseases, Respiratory Comorbidities, Chronic Kidney Disease, Cancer
Related terms Acquired Immunodeficiency Syndrome, Cardiovascular Diseases, Cerebrovascular Disorders, Neoplasms, Renal Insufficiency, Chronic, Respiratory Tract Diseases, Treatment Adherence and Compliance
Enrollment 743 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov